Mechanical Dispersion in Dilated and Non-Dilated Left Ventricular Cardiomyopathy: A New Frontier in Arrhythmic Risk

Nicoleta-Cosmina Hart-Foia1,2, Alexandra Dădârlat-Pop1,3, Renata Agoston2

  • 14th Department of Internal Medicine, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.

Insights

Mechanical dispersion (MD) may improve sudden cardiac death (SCD) risk prediction in cardiomyopathy patients. This echocardiography marker identifies higher arrhythmic risk, independent of traditional measures like ejection fraction.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Electrophysiology

Background:

  • Sudden cardiac death (SCD) remains a significant risk in dilated (DCM) and non-dilated left ventricular cardiomyopathy (NDLVC).
  • Current risk stratification using ejection fraction, scar burden, and genetics is insufficient for accurate prediction.
  • Mechanical dispersion (MD) from speckle-tracking echocardiography offers a potential marker for arrhythmic risk by assessing regional contraction timing variability.

Purpose of the Study:

  • To review the predictive value of MD for ventricular arrhythmias (VA) and SCD in DCM and NDLVC.
  • To examine the relationship between MD, myocardial fibrosis (MF), and established echocardiographic markers.

Main Methods:

  • Narrative review of prospective and retrospective studies.
  • Analysis of data from speckle-tracking echocardiography for MD calculation.
  • Comparison of MD with left ventricular ejection fraction (LVEF), global longitudinal strain (GLS), and late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR).

Main Results:

  • Increased MD consistently predicts higher arrhythmic risk in DCM patients, often independent of LVEF and GLS.
  • Risk prediction thresholds for MD range from 50 ms to 90 ms, with significant hazard ratios.
  • The correlation between MD and myocardial fibrosis (MF) is complex; VA can occur with or without detectable fibrosis, suggesting other contributing factors.

Conclusions:

  • Mechanical dispersion (MD) shows promise for enhancing SCD risk stratification in DCM and NDLVC.
  • MD may capture arrhythmogenic substrate components missed by conventional markers.
  • Further research is needed to fully elucidate the mechanisms linking MD, fibrosis, and arrhythmias.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
803
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
855
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
707
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
909
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K